Obesity is a known risk factor for acid reflux, and the weight loss achieved through semaglutide treatment has, in some cases, led to a reduction in acid reflux symptoms
Conventional L-amino acid peptides are rapidly degraded by proteases (half-life of minutes in biological fluids)
Li D, Wang T, Shen S et al (2017) Urinary tract and genital infections in patients with type 2 diabetes treated with sodium-glucose co-transporter 2 inhibitors: a meta-analysis of randomized controlled trials
This can contribute to issues like poor blood sugar control, increased hunger, and weight gain
Instead of aiming immediately toward standard therapeutic dose levels, microdosing focuses on smaller medication exposure, slower escalation, and a gentler patient experience
Bexagliflozin B